An anonymous director reports

CANOPY GROWTH TO REPORT FOURTH QUARTER AND FISCAL YEAR 2022 FINANCIAL RESULTS ON MAY 27, 2022

Canopy Growth Corp. will release its financial results for the fourth quarter and fiscal year 2022 ended March 31, 2022, before financial markets open on May 27, 2022.

Following the release of its fourth quarter and fiscal year 2022 financial results, Canopy Growth will host an audio webcast with David Klein, chief executive officer, and Judy Hong, chief financial officer, at 10 a.m. ET on May 27, 2022.

Beginning this quarter, the company will be using a question-and-answer platform developed by Say Technologies to enhance engagement with its shareholders, allowing verified retail and institutional shareholders to submit and upvote questions. Management will address a limited number of questions relating to Canopy Growth's business and financial results during the Q&A portion of the conference call. The platform will open on May 20, 2022, at 10 a.m. ET and close on May 26, 2022, at 10 a.m. ET.

Shareholders can submit questions, after the platform opens.

Replay information

A replay will be accessible by webcast until 11:59 p.m. ET on Aug. 25, 2022.

About Canopy Growth Corp.

Canopy Growth is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, the company offers product varieties in high-quality dried flower, oil, softgel capsule, infused beverage, edible and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. The company's global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany. Through Canopy's award-winning Tweed and Tokyo Smoke banners, the company reaches its adult-use consumers and has built a loyal following by focusing on top quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including Canada, the United States and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions; and has introduced additional hemp derived CBD products to the United States through our First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands.

We seek Safe Harbor.